Rubin Lab

RECENT LAB PUBLICATIONS

Cost-effectiveness Analysis of a Fecal Microbiota Transplant Center for Treating Recurrent C.difficile Infection. 
Shaffer S, Rubin DT, Targownik L, Singh H, Witt J, Kao D, Lee C, Bernstein C. J Infect. 2020. [Epub ahead of print September 24 2020].

Black Race and Public Insurance Are Predictive of Inappropriate Evaluation of Iron Deficiency Anemia and Diarrhea.
Anyane-Yeboa A, Li B, Traboulsi C, Erondu AI, Sossenheimer P, Rai V, Rubin DT. Digest Dis Sci. 2020. [Epub ahead of print July 7 2020].

Segmental Histologic Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Oucomes.
Christensen B, Hanauer SB, Gibson PR, Turner JR, Hart J, Rubin DT. J Crohns Colitis. 2020;14(10):1345-1353. PMID: 32267926.

Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients with Inflammatory Bowel Disease.
Patel P, Gao G, Gulotta G, Dalal D, Cohen RD, Sakuraba A, Rubin DT, Pekow J. Inflamm Bowel Dis. 2020. [Epub ahead of print March 27 2020]. PMID: 32219391.

Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study.
Yvellez OV, Rai V, Sossenheimer PH, Hart J, Turner JR, Weber C, El Jurdi K, Rubin DT. Inflamm Bowel Dis. 2020. [Epub ahead of print March 10 2020]. PMID: 32152624.

Effectiveness of Ustekinumab Dose Escalation in Patients with Crohn’s Disease.
Ollech JE, Normatov I, Peleg N, Wang J, Patel SA, Rai V, Yi Y, Singer J, Dalal SR, Sakuraba A, Cohen RD, Rubin DT, Pekow J. Clin Gastroenterol Hepatol. 2020. [Epub ahead of print February 26 2020]. PMID: 32109634.